Peculiar purpuric macules - 20/07/16
Doi : 10.1016/j.jaad.2015.11.016
Teo Soleymani, MD a, ⁎ 
, Jashin J. Wu, MD b
, Jashin J. Wu, MD b a The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York
b Department of Dermatology, Kaiser Permanente Los Angeles, Los Angeles, California
∗Correspondence to: Teo Soleymani, MD, The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, 240 E 38th St, 11th fl, New York, NY 10016.The Ronald O. Perelman Department of DermatologyNew York University School of Medicine240 E 38th St, 11th flNew YorkNY10016
| Funding sources: None. |
|
| Dr Wu has received research funding from AbbVie, Amgen, AstraZeneca, Coherus Biosciences, Dermira, Eli Lilly, Janssen, Merck, Novartis, Pfizer, Regeneron, Sandoz, and Sun Pharmaceutical Industries, and is a consultant for AbbVie, Amgen, Celgene, Dermira, Eli Lilly, Pfizer, and Sun Pharmaceutical Industries. Dr Soleymani has no conflicts of interest to declare. |
© 2015
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 75 - N° 2
P. e49-e50 - agosto 2016 Ritorno al numero
Articolo precedente
- Keratotic papules with loss of the lateral eyebrows
- Lucette Teel Liddell, Michael T. Cosulich, Robert T. Brodell, Stephanie K. Jacks
- Persistent violaceous patches on the face
- Tony Nguyen, Anand N. Rajpara
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?